Report Detail

Medical Devices & Consumables Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022

  • RnM3925053
  • |
  • 12 March, 2020
  • |
  • Global
  • |
  • 454 Pages
  • |
  • IQ4I Research & Consultancy
  • |
  • Medical Devices & Consumables

Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare system. Increase in occurrence of hospital acquired infections and advancements in sterilization and disinfection technologies are making the infection prevention and control market promising. For reduction of hospital acquired infections, infection prevention control organizations are applying epidemiologic and scientific principles and statistic analysis. Along with this, from the past decade there is a progressive refinement in sterilizing technologies from manually operated equipment to modern microprocessor controlled automatic machines. Plasma sterilization and use of electrostatics for surface disinfection are emerging and promising technologies in sterilizers and disinfectant market. Infection control products are used in a wide variety of applications like in healthcare settings, food and beverage industries, drug discovery, dental clinics and cosmetics. In recent times there is an advancement in sterilizing surgical tools in hospital settings by using robotic surgical tool sterilization process and thus promoting sufficient process of sterilization.
The global infection control market is expected to grow at a single digit high CAGR% to reach $22,582 million by 2022. Infection control market is mainly classified into products and end-users.
The infection control market by products is segmented into disinfection and sterilization. The disinfection market is further sub-segmented into the disinfectors which include washers, flushers and UV rays disinfectors, the endoscope reprocessors, the disinfectants and personal protective equipments (PPE). The disinfectants are divided by product type and EPA classification. Hand, skin, instrument and surface disinfectants are categorized under product type while low-level, intermediate level and high level disinfectants are divided under EPA classification segment. The personal protective equipment includes gloves and foot covers, surgical masks and respirators, surgical drapes and gowns, disinfectant wipes and others (protective eye-wears and sterilization wraps).
The infection control by sterilization is classified by methods and services. The sterilization market by method involves the heat sterilization which further includes wet/moist heat sterilization and dry sterilization, the low temperature sterilization including ethylene oxide sterilization (ETO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, peracetic acid, ozone gas, formaldehyde sterilization and chlorine dioxide, the filtration sterilization and the radiation sterilization contains ionizing and non-ionizing radiation. However the sterilization market by services is segmented into in-house sterilization services and contract sterilization services. Both the in-house and contract sterilization provides ethylene oxide sterilization, gamma sterilization, e-beam sterilization and other sterilization services.
The end-users of infection control market are pharmaceuticals, biotechnology, hospitals, research laboratories and others. The hospital end-user segment consists of dental clinics, nursing centres and ambulatory services, while the other end-users of this market are cosmetics, food and beverage and veterinary.
Among the products, disinfection segment holds the largest share and sterilization is the fastest growing segment from 2015 to 2022. By end-users, hospital is the largest segment and is the fastest segment from 2015 to 2022. Geographical wise, North America is the largest market, with a share of 39.5% followed by Europe, Asia and Rest of the World. The Asia region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Infection prevention and control market. Growth in the Asia-Pacific market is attributed to implementation of practical evidence based, low cost and simple preventive strategies, obtaining fund research projects via ICMR, DBT and state agencies and training infection control professionals and nurses.
The Infection Control market is expected to grow at a single digit high CAGR during 2015 to 2022. The factors driving the growth of this market are increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people. While rise in trend for e-beam radiation sterilization through service sterilization industry and growth of single use technology products in developing countries are some of the opportunities that are propelling the growth of the market. However stringent regulations and economic downturn and saturation are hampering the growth of the market.
The Infection Control global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infection control market are 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International, Inc., (U.S.) and Steris Corporation (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)


1 EXECUTIVE SUMMARY 31

    2 INTRODUCTION 38

    • 2.1 KEY TAKE AWAYS 38
    • 2.2 REPORT DESCRIPTION 38
    • 2.3 MARKETS COVERED 41
    • 2.4 STAKEHOLDERS 43
    • 2.5 RESEARCH METHODOLOGY 44
      • 2.5.1 MARKET SIZE ESTIMATION 45
      • 2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 48
      • 2.5.3 SECONDARY SOURCES 49
      • 2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 50
      • 2.5.5 PRIMARY SOURCES 51
      • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 51
      • 2.5.7 ASSUMPTIONS 51

    3 MARKET ANALYSIS 53

    • 3.1 INTRODUCTION 53
    • 3.2 MARKET SEGMENTATION 54
    • 3.3 FACTORS INFLUENCING MARKET 56
      • 3.3.1 DRIVERS AND OPPORTUNITIES 57
        • 3.3.1.1 Increase in aging population 57
        • 3.3.1.2 Increase in number of surgeries performed 57
        • 3.3.1.3 Rising occurrence of hospital acquired infections 58
        • 3.3.1.4 Increasing awareness among people 59
        • 3.3.1.5 Proper maintenance of hygiene among hospital staff 60
        • 3.3.1.6 Rise in trend for e-beam radiation sterilization through service

      sterilization industry 61

      • 3.3.1.7 Single use technology (medical non-woven) products, an opportunity

    especially in developing countries 61

    • 3.3.2 RESTRAINTS & THREATS 62
      • 3.3.2.1 Economic downturn and saturation of market in developed countries 62
      • 3.3.2.2 High cost of robotic technologies 63
      • 3.3.2.3 Stringent regulations 64
      • 3.3.2.4 Availability of alternative technologies 65
    • 3.3.3 CHALLENGES 66
      • 3.3.3.1 Sterilization and disinfection of advanced medical instruments 66
  • 3.4 PORTER’S FIVE FORCE ANALYSIS 67
    • 3.4.1 THREAT OF NEW ENTRANTS 68
    • 3.4.2 THREAT OF SUBSTITTES 68
    • 3.4.3 BARGAINING POWER OF SUPPLIERS 69
    • 3.4.4 BARGAINING POWER OF BUYERS 69
    • 3.4.5 RIVALRY AMONG EXISTING COMPETITORS 69
  • 3.5 REGULATORY GUIDELINES 70
    • 3.5.1 UNITED STATES 70
    • 3.5.2 EUROPE 72
    • 3.5.3 CHINA 73
    • 3.5.4 AUSTRALIA 75
  • 3.6 PATENT TRENDS 76
  • 3.7 INFECTIONS 78
    • 3.7.1 MICROBIAL INFECTIONS 78
      • 3.7.1.1 Bacterial infections 78
      • 3.7.1.1.1 Mycobacterium tuberculosis 79
      • 3.7.1.1.2 Clostridium difficile 79
      • 3.7.1.1.3 Escherichia coli 80
      • 3.7.1.1.4 Helicobacter pylori 81
      • 3.7.1.1.5 Salmonella 81
      • 3.7.1.1.6 Others 82
      • 3.7.1.2 Viral infections 83
      • 3.7.1.2.1 Ebola 83
      • 3.7.1.2.2 Human immunodeficiency virus (HIV) 84
      • 3.7.1.2.3 Herpes simplex virus 86
      • 3.7.1.2.4 Yellow fever 86
      • 3.7.1.2.5 Dengue fever 87
      • 3.7.1.2.6 Others 88
      • 3.7.1.3 Fungal infections 88
      • 3.7.1.3.1 Cryptococcus gatti 89
      • 3.7.1.3.2 Aspergillus 89
      • 3.7.1.3.3 Pneumocystis jiroveci 89
      • 3.7.1.3.4 Fungal keratitis 90
      • 3.7.1.3.5 Dermatophytosis 90
      • 3.7.1.3.6 Others 91
      • 3.7.2 HEALTHCARE ASSOCIATED INFCETIONS (HCAI) 92
        • 3.7.2.1 Hospital acquired infections (HAI) 93
        • 3.7.2.1.1 Central-line associated bloodstream infection (CLABSI) 94
        • 3.7.2.1.2 Catheter associated urinary tract infection (CAUTI) 95
        • 3.7.2.1.3 Surgical site infection (SSI) 96
        • 3.7.2.1.4 Ventilator-associated pneumonia infection (VAPI) 97
        • 3.7.2.2 Community acquired infection 97
        • 3.7.2.2.1 Methicillin-resistant staphylococcus aureus (MRSA) infection 98
        • 3.7.2.2.2 Community acquired pneumonia 99
        • 3.8 OTHER STERILIZATION AND DISINFECTION TECHNIQUES 100
          • 3.8.1 SUPERCRITICAL CARBON-DIOXIDE TECHNOLOGY (SF-CO2) 100
          • 3.8.2 NITROGEN DIOXIDES (NO2) 101
          • 3.8.3 PULSED ELECTRICAL FIELD (PEF) STERILIZATION 102
          • 3.8.4 MICROWAVE ENERGY STERILIZATION 102
          • 3.8.5 PHOTOCATALYSIS 104
          • 3.8.6 ULTRASONIC TECHNOLOGY 105
        • 3.9 MARKET SHARE ANALYSIS 107

        4 INFECTION CONTROL GLOBAL MARKET, BY PRODUCTS 110

        • 4.1 INTRODUCTION 110
        • 4.2 DISINFECTION 112
          • 4.2.1 INTRODUCTION 112
          • 4.2.2 DISINFECTORS 116
            • 4.2.2.1 Washer disinfectors 120
            • 4.2.2.2 Flushers disinfectors 123
            • 4.2.2.3 UV rays disinfectors 125
          • 4.2.3 ENDOSCOPE REPROCESSORS 128
          • 4.2.4 DISINFECTANTS 130
            • 4.2.4.1 By product type 133
            • 4.2.4.1.1 Hand 136
            • 4.2.4.1.2 Skin 139
            • 4.2.4.1.3 Surface 140
            • 4.2.4.1.4 Instrument 143
            • 4.2.4.2 By environmental protection agency (EPA) classification 145
            • 4.2.4.2.1 Low-level disinfectants (LLD) 147
            • 4.2.4.2.2 Intermediate-level disinfectants (ILD) 148
            • 4.2.4.2.3 High-level disinfectants (HLD) 150
            • 4.2.5 PERSONAL PROTECTIVE EQUIPMENTS 151
              • 4.2.5.1 Gloves and foot covers 154
              • 4.2.5.2 Surgical masks and respirators 158
              • 4.2.5.3 Surgical drapes and gowns 161
              • 4.2.5.4 Disinfectant wipes 163
              • 4.2.5.5 Others 165
              • 4.2.5.5.1 Protective eye-wears 165
              • 4.2.5.5.2 Sterilization wraps 167
              • 4.3 STERILIZATION 169
                • 4.3.1 INTRODUCTION 169
                • 4.3.2 STERILIZATION, BY METHOD 172
                  • 4.3.2.1 Heat sterilization 175
                  • 4.3.2.1.1 Wet/Moist heat sterilization 178
                  • 4.3.2.1.2 Dry heat sterilization 185
                  • 4.3.2.1.3 Low temperature sterilization 188
                  • 4.3.2.1.4 Filtration sterilization 205
                  • 4.3.2.1.5 Radiation sterilization 207
                  • 4.3.3 STERILIZATION BY SERVICES 212
                    • 4.3.3.1 In-house sterilization services 215
                    • 4.3.3.1.1 Ethylene oxide sterilization 219
                    • 4.3.3.1.2 E-beam sterilization 220
                    • 4.3.3.1.3 Gamma sterilization 222
                    • 4.3.3.1.4 Other in-house sterilization services 224
                    • 4.3.3.2 Contract sterilization services 226
                    • 4.3.3.2.1 Ethylene oxide sterilization 230
                    • 4.3.3.2.2 E-beam sterilization 231
                    • 4.3.3.2.3 Gamma sterilization 233
                    • 4.3.3.2.4 Other contract sterilization services 234

                    5 INFECTION CONTROL GLOBAL MARKET, BY END-USERS 236

                    • 5.1 INTRODUCTION 236
                    • 5.2 PHARMACEUTICALS 238
                    • 5.3 BIOTECHNOLOGY 240
                    • 5.4 HOSPITALS 242
                      • 5.4.1 DENTAL CLINICS 245
                      • 5.4.2 NURSING CENTERS 246
                      • 5.4.3 AMBULATORY SURGICAL CENTRES 248
                    • 5.5 RESEARCH LABORATORIES 249
                    • 5.6 OTHERS 251
                      • 5.6.1 COSMETICS 251
                      • 5.6.2 FOOD AND BEVERAGE 252
                      • 5.6.3 VETERINARY 253

                    6 REGIONAL ANALYSIS 255

                    • 6.1 INTRODUCTION 255
                    • 6.2 NORTH AMERICA 257
                      • 6.2.1 UNITED STATES 258
                      • 6.2.2 CANADA 259
                    • 6.3 EUROPE 279
                    • 6.4 ASIA-PACIFIC 301
                      • 6.4.1 INDIA 302
                      • 6.4.2 CHINA 303
                      • 6.4.3 JAPAN 304
                    • 6.5 REST OF THE WORLD 325
                      • 6.5.1 SOUTH AFRICA 325
                      • 6.5.2 MIDDLE EAST 326

                    7 COMPETITIVE LANDSCAPE 347

                    • 7.1 INTRODUCTION 347
                    • 7.2 NEW PRODUCT LAUNCHES 348
                    • 7.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES 351
                    • 7.4 APPROVALS 353
                    • 7.5 EXPANSIONS 354
                    • 7.6 MERGERS & ACQUISITIONS 356

                    8 MAJOR COMPANIES 362

                    • 8.1 3M COMPANY 362
                      • 8.1.1 OVERVIEW 362
                      • 8.1.2 FINANCIALS 363
                      • 8.1.3 PRODUCT PORTFOLIO 366
                      • 8.1.4 KEY DEVELOPMENTS 367
                      • 8.1.5 BUSINESS STRATEGY 367
                      • 8.1.6 SWOT ANALYSIS 368
                    • 8.2 ANSELL LIMITED 369
                      • 8.2.1 OVERVIEW 369
                      • 8.2.2 FINANCIALS 370
                      • 8.2.3 PRODUCT PORTFOLIO 372
                      • 8.2.4 KEY DEVELOPMENTS 377
                      • 8.2.5 BUSINESS STRATEGY 378
                      • 8.2.6 SWOT ANALYSIS 379
                    • 8.3 CANTEL MEDICAL 380
                      • 8.3.1 OVERVIEW 380
                      • 8.3.2 FINANCIALS 381
                      • 8.3.3 PRODUCT PORTFOLIO 383
                      • 8.3.4 KEY DEVELOPMENTS 385
                      • 8.3.5 BUSINESS STRATEGY 388
                      • 8.3.6 SWOT ANALYSIS 389
                    • 8.4 GETINGE GROUP 390
                      • 8.4.1 OVERVIEW 390
                      • 8.4.2 FINANCIALS 391
                      • 8.4.3 PRODUCT PORTFOLIO 393
                      • 8.4.4 KEY DEVELOPMENTS 396
                      • 8.4.5 BUSINESS STRATEGY 397
                      • 8.4.6 SWOT ANALYSIS 398
                    • 8.5 HALYARD HEALTH INC. 399
                      • 8.5.1 OVERVIEW 399
                      • 8.5.2 FINANCIALS 400
                      • 8.5.3 PRODUCT PORTFOLIO 403
                      • 8.5.4 KEY DEVELOPMENTS 410
                      • 8.5.5 BUSINESS STRATEGY 412
                      • 8.5.6 SWOT ANALYSIS 413
                    • 8.6 HARTMANN 414
                      • 8.6.1 OVERVIEW 414
                      • 8.6.2 FINANCIALS 415
                      • 8.6.3 PRODUCT PORTFOLIO 417
                      • 8.6.4 KEY DEVELOPMENTS 418
                      • 8.6.5 BUSINESS STRATEGY 418
                      • 8.6.6 SWOT ANALYSIS 419
                    • 8.7 JOHNSON & JOHNSON (ADVANCED STERILIZATION PRODUCTS) 420
                      • 8.7.1 OVERVIEW 420
                      • 8.7.2 FINANCIALS 421
                      • 8.7.3 PRODUCT PORTFOLIO 423
                      • 8.7.4 KEY DEVELOPMENTS 424
                      • 8.7.5 BUSINESS STRATEGY 424
                      • 8.7.6 SWOT ANALYSIS 425
                    • 8.8 METALL ZUG (BELIMED) 426
                      • 8.8.1 OVERVIEW 426
                      • 8.8.2 FINANCIALS 427
                      • 8.8.3 PRODUCT PORTFOLIO 429
                      • 8.8.4 KEY DEVELOPMENTS 431
                      • 8.8.5 BUSINESS STRATEGY 431
                      • 8.8.6 SWOT ANALYSIS 432
                    • 8.9 STERIGENICS INTERNATIONAL, INC. 433
                      • 8.9.1 OVERVIEW 433
                      • 8.9.2 FINANCIALS 433
                      • 8.9.3 PRODUCT PORTFOLIO 434
                      • 8.9.4 KEY DEVELOPMENTS 434
                      • 8.9.5 BUSINESS STRATEGY 437
                      • 8.9.6 SWOT ANALYSIS 438
                    • 8.10 STERIS CORPORATION 439
                      • 8.10.1 OVERVIEW 439
                      • 8.10.2 FINANCIALS 440
                      • 8.10.3 PRODUCT PORTFOLIO 442
                      • 8.10.4 KEY DEVELOPMENTS 450
                      • 8.10.5 BUSINESS STRATEGY 452
  • Summary:
    Get latest Market Research Reports on Infection Control (Disinfection & Sterilization). Industry analysis & Market Report on Infection Control (Disinfection & Sterilization) is a syndicated market report, published as Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022. It is complete Research Study and Industry Analysis of Infection Control (Disinfection & Sterilization) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,950.00
    $6,750.00
    $9,000.00
    3,890.70
    5,305.50
    7,074.00
    4,677.75
    6,378.75
    8,505.00
    768,240.00
    1,047,600.00
    1,396,800.00
    417,978.00
    569,970.00
    759,960.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report